Sessions at a Glance Other Events: PRE-ANNUAL MEETING SEMINARS (Registration Required) 12:30 PM Thursday–11:00 AM Friday Hematology for the Oncologist | S105 Improving Quality of Cancer Care and Patient Safety for High-Value Oncology Practice | S404 Clinical Care in Oncology for the Advanced Practice Provider | S103 Genetics and Genomics for the Practicing Clinician | S100a New Drugs in Oncology | S100bc 1:00 PM 2:00 3:00 4:00 5:00 Special Sessions Breast Cancer MTP: BRCA Mutation-Associated Breast Cancer: Local and Systemic Treatment Considerations | E451a ED: Frontiers in Precision Medicine: Practical Application of Genomic Tools in Breast Cancer Management | E Hall D1 ED: 50 Years of Advances in Breast Cancer Treatment: What Have We Learned? Where Are We Going? | E Hall D1 Cancer Genetics Cancer Prevention/ Epidemiology EXT ED: Celebrating the 50th Anniversary of the Surgeon General’s Report on Tobacco: Renewing Our Commitment to Effective Cancer Treatment and Control | S100a ED: Updates in Prostate Cancer Risk and Prevention | S504 Central Nervous System Tumors Poster Highlights Session: Central Nervous System Tumors Display: 1:00 PM-4:00 PM, E354b | Networking with Experts: 3:00 PM-4:00 PM, E354b | Discussion: 4:30 PM-5:45 PM, E450 MTP: Primary Central Nervous System Lymphoma: Past, Present, and Future | E451a Clinical Trials Developmental Therapeutics Poster Highlights Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics Display: 1:00 PM-4:00 PM, E354b | Networking with Experts: 3:00 PM-4:00 PM, E354b | Discussion: 4:30 PM-5:45 PM, E Arie Crown Theater EXT ED: Immunology for Nonimmunologists | E354a Ethics Gastrointestinal (Colorectal) Cancer ED: 50 Years of Fluorouracil, Radiation, and Surgery: What We’ve Learned, Recent Advances, and How to Treat Patients Today | E Arie Crown Theater Gastrointestinal (Noncolorectal) Cancer ED: Update on Clinical Management of Esophagogastric Cancer | E Arie Crown Theater Genitourinary Cancer Poster Highlights Session: Genitourinary (Nonprostate) Cancer Display: 1:00 PM-4:00 PM, S102 | Networking with Experts: 3:00 PM-4:00 PM, Outside S101 | Discussion: 4:30 PM-5:45 PM, S100bc MTP: A New Age of Immunotherapy in Genitourinary Tumors? | E451a Geriatric Oncology ED: Preparing for an Epidemic: Cancer Care in an Aging Population | E253 ED: Personalizing Therapy for Elderly Patients with Lymphoid Malignancies | E253 ED: Why Functional Age Matters: Care for Older Patients with Prostate and Bladder Cancer | E253 Gynecologic Cancer Head and Neck Cancer ED: Value Assessment of Therapeutic Options in Head and Neck Cancer Care | E450 ED: Head and Neck Cancer: The Best of the Rest | E450 Health Services Research EXT ED: Can We Find Common Ground? Stakeholder Perspectives on Value in Cancer Care | S100a Leukemia, Myelodysplasia, and Transplantation Lung Cancer ED: 50 Years of Lung Cancer: The Current Status of Therapy for Non-Small Cell Lung Cancer—Adjuvant Therapy, Chemoradiotherapy, and Systemic Treatment | E Hall D1 Lymphoma and Plasma Cell Disorders Poster Highlights Session: Lymphoma and Plasma Cell Disorders Display: 1:00 PM-4:00 PM, S405 | Networking with Experts: 3:00 PM-4:00 PM, Between S405 and S406 | Discussion: 4:30 PM-5:45 PM, S406 Melanoma/Skin Cancers Patient and Survivor Care EXT ED: Fertility Preservation: State of the Art and Future Directions | S504 Pediatric Oncology Practice Management and Information Technology Professional Development EXT ED: On the Shoulders of Giants: Prostate Cancer Therapy—How We Got Here and Where We Are Going | S406 EXT ED: Why I Love the Career I Chose | S404 EXT ED: Maintenance of Certification and Lifelong Learning Workshop | E451b EXT ED: Grant Writing Workshop | S103 ED: Special Session for Program Directors and Key Clinical Faculty: Intragenerational Learning—Teaching Millennial Learners and Practical Use of Milestones | E350 Sarcoma Tumor Biology EXT ED: Tumor Genomic Profiling and the Application to Personalized Medicine: Looking to the Future | S100bc ED: From Signaling Pathways to Therapeutics: What Are the Targets? | E354a Friday, May 30 CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session SPS = Special Session MTP = Meet the Professor Session (ticketed) CPO = Clinical Problems in Oncology Session (ticketed) = 50th Anniversary Session
8
Embed
Sessions at a Glance - cmt.com.cnpic1.cmt.com.cn/newspic/files/AM14-grids-8x10-FINAL.pdf · Sessions at a Glance Other Events: PRE-ANNUAL MEETING SEMINARS (Registration Required)
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
12:30 PM Thursday–11:00 AM FridayHematology for the Oncologist | S105Improving Quality of Cancer Care and Patient Safety for High-Value Oncology Practice | S404Clinical Care in Oncology for the Advanced Practice Provider | S103Genetics and Genomics for the Practicing Clinician | S100aNew Drugs in Oncology | S100bc
1:00 PM 2:00 3:00 4:00 5:00Special Sessions
Breast Cancer
MTP: BRCA Mutation-Associated Breast Cancer: Local and Systemic Treatment Considerations | E451a
ED: Frontiers in Precision Medicine: Practical Application of Genomic Tools in Breast Cancer Management | E Hall D1
ED: 50 Years of Advances in Breast Cancer Treatment: What Have We Learned? Where Are We Going? | E Hall D1
Cancer Genetics
Cancer Prevention/Epidemiology
EXT ED: Celebrating the 50th Anniversary of the Surgeon General’s Report on Tobacco: Renewing Our Commitment to Effective Cancer Treatment and Control | S100a
ED: Updates in Prostate Cancer Risk and Prevention | S504
Central Nervous System Tumors
Poster Highlights Session: Central Nervous System Tumors Display: 1:00 PM-4:00 PM, E354b | Networking with Experts: 3:00 PM-4:00 PM, E354b | Discussion: 4:30 PM-5:45 PM, E450
MTP: Primary Central Nervous System Lymphoma: Past, Present, and Future | E451a
MTP: A New Age of Immunotherapy in Genitourinary Tumors? | E451a
Geriatric Oncology ED: Preparing for an Epidemic: Cancer Care in an Aging Population | E253
ED: Personalizing Therapy for Elderly Patients with Lymphoid Malignancies | E253
ED: Why Functional Age Matters: Care for Older Patients with Prostate and Bladder Cancer | E253
Gynecologic Cancer
Head and Neck Cancer ED: Value Assessment of Therapeutic Options in Head and Neck Cancer Care | E450
ED: Head and Neck Cancer: The Best of the Rest | E450
Health Services Research
EXT ED: Can We Find Common Ground? Stakeholder Perspectives on Value in Cancer Care | S100a
Leukemia, Myelodysplasia, and Transplantation
Lung Cancer
ED: 50 Years of Lung Cancer: The Current Status of Therapy for Non-Small Cell Lung Cancer—Adjuvant Therapy, Chemoradiotherapy, and Systemic Treatment | E Hall D1
Lymphoma and Plasma Cell Disorders
Poster Highlights Session: Lymphoma and Plasma Cell Disorders Display: 1:00 PM-4:00 PM, S405 | Networking with Experts: 3:00 PM-4:00 PM, Between S405 and S406 | Discussion: 4:30 PM-5:45 PM, S406
Melanoma/Skin Cancers
Patient and Survivor Care EXT ED: Fertility Preservation: State of the Art and Future Directions | S504
Pediatric Oncology
Practice Management and Information Technology
Professional Development
EXT ED: On the Shoulders of Giants: Prostate Cancer Therapy—How We Got Here and Where We Are Going | S406 EXT ED: Why I Love the Career I Chose | S404
EXT ED: Maintenance of Certification and Lifelong Learning Workshop | E451b
EXT ED: Grant Writing Workshop | S103
ED: Special Session for Program Directors and Key Clinical Faculty: Intragenerational Learning—Teaching Millennial Learners and Practical Use of Milestones | E350
Sarcoma
Tumor Biology EXT ED: Tumor Genomic Profiling and the Application to Personalized Medicine: Looking to the Future | S100bc
ED: From Signaling Pathways to Therapeutics: What Are the Targets? | E354a
Friday, May 30CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session SPS = Special Session
MTP = Meet the Professor Session (ticketed) CPO = Clinical Problems in Oncology Session (ticketed) = 50th Anniversary Session
Saturday, May 31 CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session
Special SessionsOpening Session with Fellows of the American Society of Clinical Oncology, Guest Speaker’s Address, Presidential Address, ASCO Humanitarian Award, and David A. Karnofsky Memorial Award and Lecture | N Hall B1
Pediatric Oncology Award and Lecture | S504ASCO/American Association for Cancer Research (AACR) Joint Session: Inflammatory Cells and Cancer | S100a
B. J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology | S100a
Breast Cancer
CPO: Breast Cancer Central Nervous System Metastases: A Strategic Approach to Integrating Local and Systemic Therapies | E451b
CSS: Harnessing Biology and Immunology to Develop Novel Biomarkers | N Hall B1 Oral Abstract Session: Breast Cancer—HER2/ER | N Hall B1
Cancer GeneticsCancer Prevention/Epidemiology
ED: Progress in Prevention and Opportunities for the Future | S100bc Oral Abstract Session: Cancer Prevention/Epidemiology | S100bc
Central Nervous System Tumors
CSS: Incorporating Advanced MR and PET Imaging in the Clinic: Are We Ready? | E450 General Poster Session: Central Nervous System Tumors | S Hall A
ED: Radiotherapy for Central Nervous System Tumors: Harnessing Radioactivity from Curie to Cure | E450
Clinical Trials ED: The Changing Landscape of Federally Sponsored Trials | S100a
ED: Practical Considerations in the Design of Clinical Trials of Targeted Therapies and Immunotherapy | S100a
Developmental Therapeutics
CSS: Emerging Combination Strategies | E Arie Crown Theater
Oral Abstract Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics | E Hall D2
ED: Companion Diagnostics and Biomarker Development in Oncology Drug Development | S100bc
CPO: Optimizing the Use of New Targeted Therapies in the Face of Toxicity | E451b
EthicsED: The Value of Cancer Care, and the Professional and Ethical Obligations of the Practicing Oncologist: A Debate | E253
ED: Tumor Genomic Profiling in Cancer Care: Field of Dreams or Ethical Minefield? | E253
Gastrointestinal (Colorectal) Cancer
General Poster Session: Gastrointestinal (Colorectal) Cancer | S Hall A Poster Highlights Session: Gastrointestinal (Colorectal) Cancer Display: 1:15 PM-4:15 PM, E354b | Networking with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E Hall D2ED: The Nuts and Bolts of Liver-Directed Therapies: How Are Procedures Done, What Are the Side Effects, and What Are the Data? | E Hall D1
CPO: Treatment of Elderly Patients with Complications Related to Colorectal Cancer | E451b
Gastrointestinal (Noncolorectal) Cancer
General Poster Session: Gastrointestinal (Noncolorectal) Cancer | S Hall A
Genitourinary CancerED: Beyond Stage I Germ Cell Tumors | E Hall D2 Poster Highlights Session: Genitourinary (Prostate) Cancer
Display: 1:15 PM-4:15 PM, E354b | Networking with Experts: 3:15 PM-4:15 PM, E354b | Discussion Time: 4:45 PM-6:00 PM, E Arie Crown TheaterCSS: Unleashing the Immune System in Genitourinary Cancers | E Arie Crown Theater
Geriatric Oncology SPS: Developing a Geriatric Oncology Presence at Your Academic Institution or Community-Based Practice | S103 CSS: Outcomes and Interventions in Older Cancer Patients and Survivors | E253
Gynecologic Cancer
MTP: The Best Therapy for a Newly Diagnosed Patient with Advanced-Stage Ovarian Cancer | E451a
Oral Abstract Session: Gynecologic Cancer | E354aED: Selecting the Best Therapy for Recurrent Ovarian Cancer: Progress in Response Prediction over the Last 50 Years | E354a
General Poster Session: Gynecologic Cancer | S Hall A
Head and Neck Cancer
MTP: Intermediate Risk of Head and Neck Squamous Cell Carcinoma | E451a
General Poster Session: Head and Neck Cancer | S Hall AHealth Services Research
Leukemia, Myelodysplasia, and Transplantation
ED: Management of Acute Myeloid Leukemia in the Genomic Era | E354a
Poster Highlights Session: Leukemia, Myelodysplasia, and Transplantation Display: 1:15 PM-4:15 PM, S405 | Networking with Experts: 3:15 PM-4:15 PM, Between S405 and S406 | Discussion: 4:45 PM-6:00 PM, S406
ED: Clinical Utility of Genetic Profiling in Myeloid Malignancies | E450
Lung Cancer
CSS: Targeting EGFR: The Next 10 Years | E Hall D1 General Poster Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers | S Hall AGeneral Poster Session: Lung Cancer—Non-Small Cell Metastatic | S Hall A
MTP: Management of Oligometastatic Disease and Oligoprogression of Non-Small Cell Lung Cancer | E451a
ED: Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations | E Hall D1
Lymphoma and Plasma Cell Disorders
CSS: Targeted Therapies in Early, Mid, and Late Development | E Arie Crown Theater
MTP: Challenging Cases in T-Cell Lymphoma | E451a
Melanoma/Skin Cancers General Poster Session: Melanoma/Skin Cancers | S Hall A
ED: Frontline Approach to Metastatic BRAF Mutant Melanoma: Diagnosis, Molecular Evaluation, and Treatment Choice | S406
ED: From Coley to Cure? Past, Present, and Future of Immunotherapy for Melanoma | S406
Patient and Survivor Care
Pediatric Oncology ED: The BRAF Pathway: An Emerging Therapeutic Target in Childhood Cancer | S504 Oral Abstract Session: Pediatric Oncology I | S504
Practice Management and Information Technology
CSS: Optimizing Access to Clinical Trials in Community Practice | E253
ED: Electronic Health Records and How to Optimize Their Use | S404
ED: Community Oncology Town Hall: Ongoing and Future Issues for Practice | S404
Professional Development
ED: How to Navigate the Annual Meeting (Fellows and Junior Faculty Only) | S501
ED: Integrative Oncology: The Evidence Base | S404
ED: Burnout in Health Care Professionals: Improving the Care You Provide by Caring for Your Mental and Physical Well-being | E450
ED: MOC Open Forum: Understanding the Changes | E350
ED: Health Care in America in 2014: Current and Future Implications of the Patient Protection and Affordable Care Act | S404
SarcomaTumor Biology CSS: Advances in Tumor Biology | S406 General Poster Session: Tumor Biology | S Hall A
SPS = Special Session MTP = Meet the Professor Session (ticketed)
CPO = Clinical Problems in Oncology Session (ticketed)
Special SessionsOpening Session with Fellows of the American Society of Clinical Oncology, Guest Speaker’s Address, Presidential Address, ASCO Humanitarian Award, and David A. Karnofsky Memorial Award and Lecture | N Hall B1
Pediatric Oncology Award and Lecture | S504ASCO/American Association for Cancer Research (AACR) Joint Session: Inflammatory Cells and Cancer | S100a
B. J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology | S100a
Breast Cancer
CPO: Breast Cancer Central Nervous System Metastases: A Strategic Approach to Integrating Local and Systemic Therapies | E451b
CSS: Harnessing Biology and Immunology to Develop Novel Biomarkers | N Hall B1 Oral Abstract Session: Breast Cancer—HER2/ER | N Hall B1
Cancer GeneticsCancer Prevention/Epidemiology
ED: Progress in Prevention and Opportunities for the Future | S100bc Oral Abstract Session: Cancer Prevention/Epidemiology | S100bc
Central Nervous System Tumors
CSS: Incorporating Advanced MR and PET Imaging in the Clinic: Are We Ready? | E450 General Poster Session: Central Nervous System Tumors | S Hall A
ED: Radiotherapy for Central Nervous System Tumors: Harnessing Radioactivity from Curie to Cure | E450
Clinical Trials ED: The Changing Landscape of Federally Sponsored Trials | S100a
ED: Practical Considerations in the Design of Clinical Trials of Targeted Therapies and Immunotherapy | S100a
Developmental Therapeutics
CSS: Emerging Combination Strategies | E Arie Crown Theater
Oral Abstract Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics | E Hall D2
ED: Companion Diagnostics and Biomarker Development in Oncology Drug Development | S100bc
CPO: Optimizing the Use of New Targeted Therapies in the Face of Toxicity | E451b
EthicsED: The Value of Cancer Care, and the Professional and Ethical Obligations of the Practicing Oncologist: A Debate | E253
ED: Tumor Genomic Profiling in Cancer Care: Field of Dreams or Ethical Minefield? | E253
Gastrointestinal (Colorectal) Cancer
General Poster Session: Gastrointestinal (Colorectal) Cancer | S Hall A Poster Highlights Session: Gastrointestinal (Colorectal) Cancer Display: 1:15 PM-4:15 PM, E354b | Networking with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E Hall D2ED: The Nuts and Bolts of Liver-Directed Therapies: How Are Procedures Done, What Are the Side Effects, and What Are the Data? | E Hall D1
CPO: Treatment of Elderly Patients with Complications Related to Colorectal Cancer | E451b
Gastrointestinal (Noncolorectal) Cancer
General Poster Session: Gastrointestinal (Noncolorectal) Cancer | S Hall A
Genitourinary CancerED: Beyond Stage I Germ Cell Tumors | E Hall D2 Poster Highlights Session: Genitourinary (Prostate) Cancer
Display: 1:15 PM-4:15 PM, E354b | Networking with Experts: 3:15 PM-4:15 PM, E354b | Discussion Time: 4:45 PM-6:00 PM, E Arie Crown TheaterCSS: Unleashing the Immune System in Genitourinary Cancers | E Arie Crown Theater
Geriatric Oncology SPS: Developing a Geriatric Oncology Presence at Your Academic Institution or Community-Based Practice | S103 CSS: Outcomes and Interventions in Older Cancer Patients and Survivors | E253
Gynecologic Cancer
MTP: The Best Therapy for a Newly Diagnosed Patient with Advanced-Stage Ovarian Cancer | E451a
Oral Abstract Session: Gynecologic Cancer | E354aED: Selecting the Best Therapy for Recurrent Ovarian Cancer: Progress in Response Prediction over the Last 50 Years | E354a
General Poster Session: Gynecologic Cancer | S Hall A
Head and Neck Cancer
MTP: Intermediate Risk of Head and Neck Squamous Cell Carcinoma | E451a
General Poster Session: Head and Neck Cancer | S Hall AHealth Services Research
Leukemia, Myelodysplasia, and Transplantation
ED: Management of Acute Myeloid Leukemia in the Genomic Era | E354a
Poster Highlights Session: Leukemia, Myelodysplasia, and Transplantation Display: 1:15 PM-4:15 PM, S405 | Networking with Experts: 3:15 PM-4:15 PM, Between S405 and S406 | Discussion: 4:45 PM-6:00 PM, S406
ED: Clinical Utility of Genetic Profiling in Myeloid Malignancies | E450
Lung Cancer
CSS: Targeting EGFR: The Next 10 Years | E Hall D1 General Poster Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers | S Hall AGeneral Poster Session: Lung Cancer—Non-Small Cell Metastatic | S Hall A
MTP: Management of Oligometastatic Disease and Oligoprogression of Non-Small Cell Lung Cancer | E451a
ED: Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations | E Hall D1
Lymphoma and Plasma Cell Disorders
CSS: Targeted Therapies in Early, Mid, and Late Development | E Arie Crown Theater
MTP: Challenging Cases in T-Cell Lymphoma | E451a
Melanoma/Skin Cancers General Poster Session: Melanoma/Skin Cancers | S Hall A
ED: Frontline Approach to Metastatic BRAF Mutant Melanoma: Diagnosis, Molecular Evaluation, and Treatment Choice | S406
ED: From Coley to Cure? Past, Present, and Future of Immunotherapy for Melanoma | S406
Patient and Survivor Care
Pediatric Oncology ED: The BRAF Pathway: An Emerging Therapeutic Target in Childhood Cancer | S504 Oral Abstract Session: Pediatric Oncology I | S504
Practice Management and Information Technology
CSS: Optimizing Access to Clinical Trials in Community Practice | E253
ED: Electronic Health Records and How to Optimize Their Use | S404
ED: Community Oncology Town Hall: Ongoing and Future Issues for Practice | S404
Professional Development
ED: How to Navigate the Annual Meeting (Fellows and Junior Faculty Only) | S501
ED: Integrative Oncology: The Evidence Base | S404
ED: Burnout in Health Care Professionals: Improving the Care You Provide by Caring for Your Mental and Physical Well-being | E450
ED: MOC Open Forum: Understanding the Changes | E350
ED: Health Care in America in 2014: Current and Future Implications of the Patient Protection and Affordable Care Act | S404
SarcomaTumor Biology CSS: Advances in Tumor Biology | S406 General Poster Session: Tumor Biology | S Hall A
Sunday, June 1 CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session
Highlights of the Day I Session Including Clinical Trials Participation Awards | E Hall D1
Plenary Session Including the Science of Oncology Award and Lecture | N Hall B1Plenary Session Simulcast, E Hall D1
Post-Plenary Discussion I: Genitourinary Cancer | S100bc
Post-Plenary Discussion III: Breast Cancer | S100bc
ASCO–American Cancer Society Award and Lecture | S100a
Post-Plenary Discussion II: Gastrointestinal Cancer | S100a
Breast CancerPoster Highlights Session: Breast Cancer—HER2/ER Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00AM, E354b | Discussion: 11:30 AM-12:45 PM, E Arie Crown Theater
ED: Streamlining Breast Cancer Care: Opportunities and Challenges | N Hall B1
Cancer Genetics
Cancer Prevention/Epidemiology
General Poster Session: Cancer Prevention/Epidemiology | S Hall AED: Hype versus Hope: Repurposing Metformin, Vitamin D, Aspirin, Beta-Blockers, and Folic Acid for Cancer | S404
Central Nervous System Tumors
Oral Abstract Session: Central Nervous System Tumors | E450ED: Tools for the Best Outcomes in the Management of Brain Metastases | E450
ED: Immunotherapy: Transforming Frustration to Cure in the Next 50 Years | E450
Clinical TrialsED: Access to Data from Clinical Trials: A New Age of Clinical Trial Transparency | S100bc
ED: 50 Years of Precision Medicine: Advances in the Field and Prospective and Innovative Randomized Clinical Trials | S100bc
ED: Developing a Usable Biomarker: Odyssey of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma— From a Journal Report to a Multinational Clinical Trial | S100a
Developmental Therapeutics
General Poster Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics | S Hall A
General Poster Session: Developmental Therapeutics— Immunotherapy | S Hall A
ED: Radiopharmaceuticals: Spanning Hematologic Malignancies to Solid Tumors | S100a
EthicsED: Eight Days a Week: Managing Cumulative Expectations for the Busy Oncology Provider | E253
Gastrointestinal (Colorectal) Cancer
ED: The Evolution of Our Molecular Understanding of Colorectal Cancer: What We Are Doing Now, What the Future Holds, and How Tumor Profiling Is Just the Beginning | E Hall D1
Gastrointestinal (Noncolorectal) Cancer
CPO: Navigating Treatment Options in Advanced Neuroendocrine Tumors | E451b
Poster Highlights Session: Gastrointestinal (Noncolorectal) Cancer Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00AM, E354b | Discussion: 11:30 AM-12:45 PM, E Hall D2
Genitourinary Cancer Oral Abstract Session: Genitourinary (Prostate) Cancer | N Hall B1
CPO: Rare Genitourinary Tumors: Lethal Prostate Cancer Variants, Non-Clear Cell Renal Cell Carcinoma, and Penile Cancer | E451b
ED: Moving Forward in Advanced Prostate Cancer Clinical Development | E Hall D2
Geriatric Oncology
Gynecologic Cancer CSS: Finding the Targets in Gynecologic Cancers | E354aED: Quality and Value in Gynecologic Cancer Care: Do We Get What We Pay For? | E354a
ED: Ovarian and Cervix Avatars: The Key to Individualized Therapy? | E354a
Head and Neck CancerCPO: Toxicity Management in Head and Neck Cancer | E451b
CSS: Immunobiology and Immunotherapy | S100bc
Health Services Research
ED: Overdiagnosis and Overtreatment in Cancer: Point/Counterpoint | E253
ED: The Present and Future of the State of the Art in Health Services Research | E253
ED: What We Can Learn from International Health Care Systems: Approaching Sustainable Cancer Care from a Global Perspective | E253
ED: The 2013 Institute of Medicine Report on Delivering Quality Cancer Care: What Needs to Happen | E354a
Leukemia, Myelodysplasia, and Transplantation
CPO: Therapeutic Advances in Myeloproliferative Neoplasms: Focus on Myelofibrosis and Chronic Myelogenous Leukemia | E451b
ED: Understanding, Exploring, and Looking at New and Future Developments in Non-Small Cell Lung Cancer Immunotherapy | E Hall D1
ED: How to Talk with Your Pathologist about Molecular Testing | E Arie Crown Theater
Lymphoma and Plasma Cell Disorders
MTP: Treatment of the Patient with High-Risk Myeloma | E451a
ED: Follow-up Imaging in Lymphoma: A Debate on Its Use | E Arie Crown Theater
Oral Abstract Session: Lymphoma | E Hall D2
Melanoma/Skin CancersCSS: Novel Combination Therapies for Melanoma | E Arie Crown Theater
MTP: Identification and Management of Systemic and Cutaneous Toxicities from Vemurafenib, Dabrafenib, Trametinib, and Ipilimumab for Melanoma | E451a
Patient and Survivor Care
General Poster Session: Patient and Survivor Care | S Hall A
ED: Accelerated Aging among Cancer Survivors: From Pediatrics to Geriatrics | S404
MTP: Ask the Specialist: Cardiac Complications of Cancer Treatments | E451a
Pediatric OncologyED: Genetic Predisposition to Survival and Survivorship: How Far Are We from Individualized Therapy? | S504
Oral Abstract Session: Pediatric Oncology II | S504MTP: Nonrhabdomyosarcoma Soft Tissue Sarcomas in Children and Young Adults | E451a
Practice Management and Information Technology
Professional Development
ED: Training Program Directors’ Breakfast | S404ED: The Future Is Now: Incorporating Electronic Health Records, Web-Based Decision Tools, and Social Media into Your Clinical Practice | S504
Sarcoma Oral Abstract Session: Sarcoma | S406ED: Novel Molecular and Metabolic Targets in Sarcoma | S406
Tumor Biology
SPS = Special Session MTP = Meet the Professor Session (ticketed)
CPO = Clinical Problems in Oncology Session (ticketed)
Highlights of the Day I Session Including Clinical Trials Participation Awards | E Hall D1
Plenary Session Including the Science of Oncology Award and Lecture | N Hall B1Plenary Session Simulcast, E Hall D1
Post-Plenary Discussion I: Genitourinary Cancer | S100bc
Post-Plenary Discussion III: Breast Cancer | S100bc
ASCO–American Cancer Society Award and Lecture | S100a
Post-Plenary Discussion II: Gastrointestinal Cancer | S100a
Breast CancerPoster Highlights Session: Breast Cancer—HER2/ER Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00AM, E354b | Discussion: 11:30 AM-12:45 PM, E Arie Crown Theater
ED: Streamlining Breast Cancer Care: Opportunities and Challenges | N Hall B1
Cancer Genetics
Cancer Prevention/Epidemiology
General Poster Session: Cancer Prevention/Epidemiology | S Hall AED: Hype versus Hope: Repurposing Metformin, Vitamin D, Aspirin, Beta-Blockers, and Folic Acid for Cancer | S404
Central Nervous System Tumors
Oral Abstract Session: Central Nervous System Tumors | E450ED: Tools for the Best Outcomes in the Management of Brain Metastases | E450
ED: Immunotherapy: Transforming Frustration to Cure in the Next 50 Years | E450
Clinical TrialsED: Access to Data from Clinical Trials: A New Age of Clinical Trial Transparency | S100bc
ED: 50 Years of Precision Medicine: Advances in the Field and Prospective and Innovative Randomized Clinical Trials | S100bc
ED: Developing a Usable Biomarker: Odyssey of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma— From a Journal Report to a Multinational Clinical Trial | S100a
Developmental Therapeutics
General Poster Session: Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics | S Hall A
General Poster Session: Developmental Therapeutics— Immunotherapy | S Hall A
ED: Radiopharmaceuticals: Spanning Hematologic Malignancies to Solid Tumors | S100a
EthicsED: Eight Days a Week: Managing Cumulative Expectations for the Busy Oncology Provider | E253
Gastrointestinal (Colorectal) Cancer
ED: The Evolution of Our Molecular Understanding of Colorectal Cancer: What We Are Doing Now, What the Future Holds, and How Tumor Profiling Is Just the Beginning | E Hall D1
Gastrointestinal (Noncolorectal) Cancer
CPO: Navigating Treatment Options in Advanced Neuroendocrine Tumors | E451b
Poster Highlights Session: Gastrointestinal (Noncolorectal) Cancer Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00AM, E354b | Discussion: 11:30 AM-12:45 PM, E Hall D2
Genitourinary Cancer Oral Abstract Session: Genitourinary (Prostate) Cancer | N Hall B1
CPO: Rare Genitourinary Tumors: Lethal Prostate Cancer Variants, Non-Clear Cell Renal Cell Carcinoma, and Penile Cancer | E451b
ED: Moving Forward in Advanced Prostate Cancer Clinical Development | E Hall D2
Geriatric Oncology
Gynecologic Cancer CSS: Finding the Targets in Gynecologic Cancers | E354aED: Quality and Value in Gynecologic Cancer Care: Do We Get What We Pay For? | E354a
ED: Ovarian and Cervix Avatars: The Key to Individualized Therapy? | E354a
Head and Neck CancerCPO: Toxicity Management in Head and Neck Cancer | E451b
CSS: Immunobiology and Immunotherapy | S100bc
Health Services Research
ED: Overdiagnosis and Overtreatment in Cancer: Point/Counterpoint | E253
ED: The Present and Future of the State of the Art in Health Services Research | E253
ED: What We Can Learn from International Health Care Systems: Approaching Sustainable Cancer Care from a Global Perspective | E253
ED: The 2013 Institute of Medicine Report on Delivering Quality Cancer Care: What Needs to Happen | E354a
Leukemia, Myelodysplasia, and Transplantation
CPO: Therapeutic Advances in Myeloproliferative Neoplasms: Focus on Myelofibrosis and Chronic Myelogenous Leukemia | E451b
ED: Understanding, Exploring, and Looking at New and Future Developments in Non-Small Cell Lung Cancer Immunotherapy | E Hall D1
ED: How to Talk with Your Pathologist about Molecular Testing | E Arie Crown Theater
Lymphoma and Plasma Cell Disorders
MTP: Treatment of the Patient with High-Risk Myeloma | E451a
ED: Follow-up Imaging in Lymphoma: A Debate on Its Use | E Arie Crown Theater
Oral Abstract Session: Lymphoma | E Hall D2
Melanoma/Skin CancersCSS: Novel Combination Therapies for Melanoma | E Arie Crown Theater
MTP: Identification and Management of Systemic and Cutaneous Toxicities from Vemurafenib, Dabrafenib, Trametinib, and Ipilimumab for Melanoma | E451a
Patient and Survivor Care
General Poster Session: Patient and Survivor Care | S Hall A
ED: Accelerated Aging among Cancer Survivors: From Pediatrics to Geriatrics | S404
MTP: Ask the Specialist: Cardiac Complications of Cancer Treatments | E451a
Pediatric OncologyED: Genetic Predisposition to Survival and Survivorship: How Far Are We from Individualized Therapy? | S504
Oral Abstract Session: Pediatric Oncology II | S504MTP: Nonrhabdomyosarcoma Soft Tissue Sarcomas in Children and Young Adults | E451a
Practice Management and Information Technology
Professional Development
ED: Training Program Directors’ Breakfast | S404ED: The Future Is Now: Incorporating Electronic Health Records, Web-Based Decision Tools, and Social Media into Your Clinical Practice | S504
Sarcoma Oral Abstract Session: Sarcoma | S406ED: Novel Molecular and Metabolic Targets in Sarcoma | S406
Tumor Biology
Monday, June 2 CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session
Highlights of the Day II Session Including Partners in Progress Award | E Hall D1
ASCO Annual Business Meeting (ASCO Members Only) | S100a
ASCO Book Club: Mountains Beyond Mountains | S103
ASCO/Radiological Society of North America (RSNA) Joint Session: Precision Imaging for Precision Medicine | S100bc
ASCO/European CanCer Organisation (ECCO) Joint Session: Value and Cancer Care | S100bc
Breast Cancer
General Poster Session: Breast Cancer—HER2/ER | S Hall A Poster Highlights Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy Display: 1:15 PM-4:15 PM, E354b | Networkng with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E Hall D1
General Poster Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy | S Hall A ED: A Brave New World: Contemporary Management of HER2-Positive Breast Cancer | N Hall B1
ED: Navigating a Changing Sea: Optimizing Treatment of Hormone Receptor–Positive Breast Cancer | N Hall B1
Cancer Genetics ED: Pharmacogenomics in the Era of Next-Generation Sequencing | S404
ED: Cancer Genomics and Inherited Risk: Recent Advances and Current Challenges | S404
ED: Hereditary Breast and Colon Cancer, and Clinical Oncology: Past, Present, and Future | S404
ED: Predisposition to Pediatric and Hematologic Cancers: A Moving Target | S404 ED: Second Cancers: Genomics and Detection | S404
Cancer Prevention/Epidemiology
CSS: Next-Generation Sequencing Panels for Cancer Risk Assessment | S100a
CPO: Breast Density: Clinical Impact and Emerging Legal Issues | E451b
Central Nervous System Tumors
ED: Medulloblastoma: Modern Molecular Diagnostics and Clinical Decision Making | E253
Clinical Trials ED: Internet, Social Media, Privacy Regulations, and Clinical Trials | S504
Developmental Therapeutics
Poster Highlights Session: Developmental Therapeutics— Immunotherapy Display: 1:15 PM-4:15 PM, S405 | Networkng with Experts: 3:15 PM-4:15 PM, Between S405 and S406 | Discussion: 4:45 PM-6:00 PM, S406
ED: Cancer Nanotechnology: Path to New Diagnostics and Therapeutics | S100bc
Ethics
Gastrointestinal (Colorectal) Cancer Oral Abstract Session: Gastrointestinal (Colorectal) Cancer | E Arie Crown Theater
Gastrointestinal (Noncolorectal) Cancer
ED: Rare but Real: Management of Pseudomyxoma Peritonei, Gallbladder Cancer, and Periampullary Cancers | N Hall B1
Oral Abstract Session: Gastrointestinal (Noncolorectal) Cancer | E Hall D1ED: The Past, Present, and Future of Noncolorectal Gastrointestinal Cancers: Have We Moved the Bar? | N Hall B1
MTP: Management of Hepatocellular Cancer: Right Patient, Right Treatment, Right Time | E451a
Genitourinary Cancer
ED: Renal Cell Carcinoma from Small Renal Masses to Advanced Disease | E Hall D2 Oral Abstract Session: Genitourinary (Nonprostate) Cancer | E Hall D1 General Poster Session: Genitourinary (Nonprostate) Cancer | S Hall A
General Poster Session: Genitourinary (Prostate) Cancer | S Hall A
ED: From Genetics to Geriatric Medicine in Bladder Cancer | E Hall D2
Geriatric Oncology
Gynecologic Cancer Poster Highlights Session: Gynecologic Cancer Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00 AM, E354b | Discussion: 11:30 AM-12:45 PM, E354a
ED: Survivorship in Gynecologic Cancer: Enduring the Treatment, Surviving the Cure | E354a
ED: Rare Gynecologic Tumors: New Targets, New Therapies | E354a
Head and Neck Cancer
Oral Abstract Session: Head and Neck Cancer | E450 Poster Highlights Session: Head and Neck Cancer Display: 1:15 PM-4:15 PM, E354b | Networkng with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E450
ED: Migration from Carcinogen to Virus: 50 Years of Evolution in Epidemiology and Treatment of Head and Neck Cancer | E450
Health Services ResearchOral Abstract Session: Health Services Research | E253 General Poster Session: Health Services Research | S Hall A2
ED: The Winds of Change: Cancer Disparities in the Health Care Reform Era | E253
Leukemia, Myelodysplasia, and Transplantation
CPO: Raising the Bar: Moving toward Improved Outcomes in Myelodysplastic Syndromes | E451b General Poster Session: Leukemia, Myelodysplasia, and Transplantation | S Hall A
ED: Chronic Lymphocytic Leukemia Therapy: An Update on Frontline and Novel Therapies | E450
Lung Cancer CPO: Multimodality Management of Non-Small Cell Lung Cancer: Curative and Palliative Care | E451b Oral Abstract Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers | E Hall D2
ED: Time to Look Again: Emerging Biology and Therapeutics in Small Cell and Large Cell Neuroendocrine Cancers, Thymoma/Thymic Carcinomas, and Mesothelioma | E Arie Crown Theater
Oral Abstract Session: Lung Cancer—Non-Small Cell Metastatic | E Hall D2
Lymphoma and Plasma Cell Disorders
Oral Abstract Session: Myeloma | E354a
CPO: Clinical Conundrums in Lymphoid Malignancies: Uncommon Problems in Common Diseases and Common Problems in Uncommon Diseases | E451b
General Poster Session: Lymphoma and Plasma Cell Disorders | S Hall A
ED: Lymphoma and Myeloma: Where We Were, Where We Are, Where We Are Going | S100a
Poster Highlights Session: Patient and Survivor Care Display: 8:00 AM-11:00 AM, S102 | Networking with Experts: 10:00 AM-11:00 AM, Outside S101 | Discussion: 11:30 AM-12:45 PM, S100b Oral Abstract Session: Patient and Survivor Care | E253
ED: Cancer Survivorship Programs Across Different Health Care Settings: Past, Present, and Future | S504
Pediatric OncologyPoster Highlights Session: Pediatric Oncology Display: 8:00 AM-11:00 AM, S Hall A | Networking with Experts: 10:00 AM-11:00 AM, S Hall A | Discussion: 11:30 AM-12:45 PM, S504
CPO: Clinical Research in Children with Cancer: Challenges and Opportunities | E451b
ED: Beyond Stage and Anaplasia: New Approaches to Risk Stratification for Wilms Tumor | S504
ED: 50 Years of Pediatric Oncology: From Chemotherapy to Genomics to Targeted Therapy | S504
General Poster Session: Pediatric Oncology | S Hall A
Practice Management and Information Technology
MTP: How to Smartly Use Smartphones, Twitter, and Social Media to Efficiently Enhance Clinical Practice | E451a
Professional Development
ED: Tumor Boards: Optimizing the Structure and Improving Efficiency of Multidisciplinary Treatment of Patients with Cancer Worldwide | S504
ED: MOC 101: Orientation to MOC Requirements | E354a
MTP: Tips for Successful Contract Negotiation | E451a
SarcomaGeneral Poster Session: Sarcoma | S Hall A CSS: Exploring the Spectrum of Sarcoma Genome | S406 CPO: Successes in Gastrointestinal Stromal Tumors:
Long-term Considerations and Survivorship | E451b
ED: Golden Jubilee: 50 Years of Advances in Sarcoma | S406
MTP: The Management of Intra-abdominal Sarcomas | E451a
Tumor Biology
Poster Highlights Session: Tumor Biology Display: 8:00 AM-11:00 AM, S405 | Networking with Experts: 10:00 AM-11:00 AM, Between S405 and S406 | Discussion: 11:30 AM-12:45 PM, S406
MTP: From Immunotherapy Research to Clinical Vaccines | E451a Oral Abstract Session: Tumor Biology | S100bc
ED: In Vivo Preclinical Models: Making Inroads into Personalized Therapy | S406
SPS = Special Session MTP = Meet the Professor Session (ticketed)
CPO = Clinical Problems in Oncology Session (ticketed)
Highlights of the Day II Session Including Partners in Progress Award | E Hall D1
ASCO Annual Business Meeting (ASCO Members Only) | S100a
ASCO Book Club: Mountains Beyond Mountains | S103
ASCO/Radiological Society of North America (RSNA) Joint Session: Precision Imaging for Precision Medicine | S100bc
ASCO/European CanCer Organisation (ECCO) Joint Session: Value and Cancer Care | S100bc
Breast Cancer
General Poster Session: Breast Cancer—HER2/ER | S Hall A Poster Highlights Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy Display: 1:15 PM-4:15 PM, E354b | Networkng with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E Hall D1
General Poster Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy | S Hall A ED: A Brave New World: Contemporary Management of HER2-Positive Breast Cancer | N Hall B1
ED: Navigating a Changing Sea: Optimizing Treatment of Hormone Receptor–Positive Breast Cancer | N Hall B1
Cancer Genetics ED: Pharmacogenomics in the Era of Next-Generation Sequencing | S404
ED: Cancer Genomics and Inherited Risk: Recent Advances and Current Challenges | S404
ED: Hereditary Breast and Colon Cancer, and Clinical Oncology: Past, Present, and Future | S404
ED: Predisposition to Pediatric and Hematologic Cancers: A Moving Target | S404 ED: Second Cancers: Genomics and Detection | S404
Cancer Prevention/Epidemiology
CSS: Next-Generation Sequencing Panels for Cancer Risk Assessment | S100a
CPO: Breast Density: Clinical Impact and Emerging Legal Issues | E451b
Central Nervous System Tumors
ED: Medulloblastoma: Modern Molecular Diagnostics and Clinical Decision Making | E253
Clinical Trials ED: Internet, Social Media, Privacy Regulations, and Clinical Trials | S504
Developmental Therapeutics
Poster Highlights Session: Developmental Therapeutics— Immunotherapy Display: 1:15 PM-4:15 PM, S405 | Networkng with Experts: 3:15 PM-4:15 PM, Between S405 and S406 | Discussion: 4:45 PM-6:00 PM, S406
ED: Cancer Nanotechnology: Path to New Diagnostics and Therapeutics | S100bc
Ethics
Gastrointestinal (Colorectal) Cancer Oral Abstract Session: Gastrointestinal (Colorectal) Cancer | E Arie Crown Theater
Gastrointestinal (Noncolorectal) Cancer
ED: Rare but Real: Management of Pseudomyxoma Peritonei, Gallbladder Cancer, and Periampullary Cancers | N Hall B1
Oral Abstract Session: Gastrointestinal (Noncolorectal) Cancer | E Hall D1ED: The Past, Present, and Future of Noncolorectal Gastrointestinal Cancers: Have We Moved the Bar? | N Hall B1
MTP: Management of Hepatocellular Cancer: Right Patient, Right Treatment, Right Time | E451a
Genitourinary Cancer
ED: Renal Cell Carcinoma from Small Renal Masses to Advanced Disease | E Hall D2 Oral Abstract Session: Genitourinary (Nonprostate) Cancer | E Hall D1 General Poster Session: Genitourinary (Nonprostate) Cancer | S Hall A
General Poster Session: Genitourinary (Prostate) Cancer | S Hall A
ED: From Genetics to Geriatric Medicine in Bladder Cancer | E Hall D2
Geriatric Oncology
Gynecologic Cancer Poster Highlights Session: Gynecologic Cancer Display: 8:00 AM-11:00 AM, E354b | Networking with Experts: 10:00 AM-11:00 AM, E354b | Discussion: 11:30 AM-12:45 PM, E354a
ED: Survivorship in Gynecologic Cancer: Enduring the Treatment, Surviving the Cure | E354a
ED: Rare Gynecologic Tumors: New Targets, New Therapies | E354a
Head and Neck Cancer
Oral Abstract Session: Head and Neck Cancer | E450 Poster Highlights Session: Head and Neck Cancer Display: 1:15 PM-4:15 PM, E354b | Networkng with Experts: 3:15 PM-4:15 PM, E354b | Discussion: 4:45 PM-6:00 PM, E450
ED: Migration from Carcinogen to Virus: 50 Years of Evolution in Epidemiology and Treatment of Head and Neck Cancer | E450
Health Services ResearchOral Abstract Session: Health Services Research | E253 General Poster Session: Health Services Research | S Hall A2
ED: The Winds of Change: Cancer Disparities in the Health Care Reform Era | E253
Leukemia, Myelodysplasia, and Transplantation
CPO: Raising the Bar: Moving toward Improved Outcomes in Myelodysplastic Syndromes | E451b General Poster Session: Leukemia, Myelodysplasia, and Transplantation | S Hall A
ED: Chronic Lymphocytic Leukemia Therapy: An Update on Frontline and Novel Therapies | E450
Lung Cancer CPO: Multimodality Management of Non-Small Cell Lung Cancer: Curative and Palliative Care | E451b Oral Abstract Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers | E Hall D2
ED: Time to Look Again: Emerging Biology and Therapeutics in Small Cell and Large Cell Neuroendocrine Cancers, Thymoma/Thymic Carcinomas, and Mesothelioma | E Arie Crown Theater
Oral Abstract Session: Lung Cancer—Non-Small Cell Metastatic | E Hall D2
Lymphoma and Plasma Cell Disorders
Oral Abstract Session: Myeloma | E354a
CPO: Clinical Conundrums in Lymphoid Malignancies: Uncommon Problems in Common Diseases and Common Problems in Uncommon Diseases | E451b
General Poster Session: Lymphoma and Plasma Cell Disorders | S Hall A
ED: Lymphoma and Myeloma: Where We Were, Where We Are, Where We Are Going | S100a
Poster Highlights Session: Patient and Survivor Care Display: 8:00 AM-11:00 AM, S102 | Networking with Experts: 10:00 AM-11:00 AM, Outside S101 | Discussion: 11:30 AM-12:45 PM, S100b Oral Abstract Session: Patient and Survivor Care | E253
ED: Cancer Survivorship Programs Across Different Health Care Settings: Past, Present, and Future | S504
Pediatric OncologyPoster Highlights Session: Pediatric Oncology Display: 8:00 AM-11:00 AM, S Hall A | Networking with Experts: 10:00 AM-11:00 AM, S Hall A | Discussion: 11:30 AM-12:45 PM, S504
CPO: Clinical Research in Children with Cancer: Challenges and Opportunities | E451b
ED: Beyond Stage and Anaplasia: New Approaches to Risk Stratification for Wilms Tumor | S504
ED: 50 Years of Pediatric Oncology: From Chemotherapy to Genomics to Targeted Therapy | S504
General Poster Session: Pediatric Oncology | S Hall A
Practice Management and Information Technology
MTP: How to Smartly Use Smartphones, Twitter, and Social Media to Efficiently Enhance Clinical Practice | E451a
Professional Development
ED: Tumor Boards: Optimizing the Structure and Improving Efficiency of Multidisciplinary Treatment of Patients with Cancer Worldwide | S504
ED: MOC 101: Orientation to MOC Requirements | E354a
MTP: Tips for Successful Contract Negotiation | E451a
SarcomaGeneral Poster Session: Sarcoma | S Hall A CSS: Exploring the Spectrum of Sarcoma Genome | S406 CPO: Successes in Gastrointestinal Stromal Tumors:
Long-term Considerations and Survivorship | E451b
ED: Golden Jubilee: 50 Years of Advances in Sarcoma | S406
MTP: The Management of Intra-abdominal Sarcomas | E451a
Tumor Biology
Poster Highlights Session: Tumor Biology Display: 8:00 AM-11:00 AM, S405 | Networking with Experts: 10:00 AM-11:00 AM, Between S405 and S406 | Discussion: 11:30 AM-12:45 PM, S406
MTP: From Immunotherapy Research to Clinical Vaccines | E451a Oral Abstract Session: Tumor Biology | S100bc
ED: In Vivo Preclinical Models: Making Inroads into Personalized Therapy | S406
Tuesday, June 3CSS = Clinical Science Symposium ED = Education Session EXT ED = Extended Education Session SPS = Special Session
MTP = Meet the Professor Session (ticketed) CPO = Clinical Problems in Oncology Session (ticketed) = 50th Anniversary Session
7:30 AM 8:00 9:00 10:00 11:00 12:00 PM
Special Sessions Highlights of the Day III Session | E Hall D1
Breast CancerED: Targeting and Tailoring Therapy for Triple-Negative Breast Cancer | S406
Oral Abstract Session: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy | E Hall D1
Cancer GeneticsCancer Prevention/EpidemiologyCentral Nervous System TumorsClinical Trials
Developmental Therapeutics
ED: Innovative Strategies for Picking Combination Therapy Regimens | S100a